Brief: Clearside Biomedical Announces Q1 2023 Financial Results, Provides Corporate Update
11/05/2023 13:24
May 11 (Reuters) - Clearside Biomedical Inc CLSD.O :
* CLEARSIDE BIOMEDICAL ANNOUNCES FIRST QUARTER 2023
FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
* CLEARSIDE BIOMEDICAL INC- NET LOSS FOR Q1 OF 2023 $0.15
PER
SHARE OF COMMON STOCK
* CLEARSIDE BIOMEDICAL INC- BELIEVES IT WILL HAVE SUFFICIENT
RESOURCES TO FUND ITS PLANNED OPERATIONS INTO Q2 OF 2024
Source text for Eikon: ID:nGNX7ZjxSS
Further company coverage: CLSD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Clearside Biomedical,
See all newsBrief: Clearside Biomedical Completes Financial Restructuring And Emerges From Chapter 11 With Steel Partners As Plan Sponsor
U.S. STOCKS ON THE MOVE-Merck, Genco, Tesla
U.S. STOCKS ON THE MOVE-Morgan Stanley, Merck, Genco
Clearside Biomedical plunges after filing for Chapter 11 bankruptcy
U.S. STOCKS ON THE MOVE-Bristol Myers Squibb, Palo Alto Networks, MP Materials